The headlines say facial filler killed him. The evidence says something more specific.

A senior Estée Lauder executive died this year of a pulmonary embolism linked to cosmetic filler, and social media has decided that lip and cheek filler can stop your heart. So I went to the primary medical literature and read every documented case I could find. Here is what it actually shows — and what it means for you.

Author Rachel Roberts ·  NMC Independent Nurse Prescriber  ·  Clinical Director, Sebastian Rose  ·  12 min read

In February 2026, Kendal Ascher — a 56-year-old senior vice president at Estée Lauder — felt lightheaded after a shower, collapsed, and died in his husband's arms. Four months later, New York City's Chief Medical Examiner released the cause: acute respiratory failure due to a pulmonary embolism of foreign material, following cosmetic filler injections.

The manner of death was ruled accidental.

Within hours, the internet did what the internet does. Filler can stop your heart. This is why I'll never get my lips done. The story collapsed into a single frightening idea — that the lip and cheek treatments millions of people have can kill you. I understand the fear. But I read the actual ruling, and then I read the actual medical literature, every documented case I could trace. The picture that emerges is far more specific, and far more useful, than the headline.

First, what was actually confirmed — and what wasn't

It's worth being precise, because two different facts are being fused into one. The Medical Examiner confirmed that filler caused the embolism — that part is established and this article doesn't dispute it. What the ruling does not state — and what no report has established — is where on the body that filler was placed. There is no anatomical site in the findings. That single missing detail is the whole story.

The reporting bears this out. Ascher's husband said he wasn't aware Kendal had had any filler at all; the one cosmetic procedure they had shared, some months earlier, was botulinum toxin — and toxin is not a filler. The press itself concedes it is unclear what product he received, or when.

So where did “buttock filler” enter the conversation? From context, not from the case file. A cosmetic dermatologist commenting on the story — who did not treat Ascher — explained that this kind of fatal embolic event is “much more classically associated with larger-volume injection in the buttocks” than with the face, and referenced a separate young woman who had died after buttock filler. That is an expert describing where this mechanism usually happens. It is not a statement that Ascher had buttock work. The two got fused in the retelling.

I'm labouring this point because the honest position is uncomfortable for a clipped headline: we do not know the site, the product or the injector. If it genuinely was facial filler, this case would stand almost alone in the world literature. If it was a large-volume body site, it sits with a small but real cluster of similar deaths. The evidence below is what lets you tell which world we're in.

0   —  published deaths from a pulmonary embolism caused by facial dermal filler.

1   —  reported case of facial-filler lung embolism, at an illegal salon. The patient survived.

~5.5 million   —  filler procedures performed in a single year, against which these events are measured.

A 60-second anatomy lesson

Two circulations, two completely different disasters

Almost all the confusion in the public conversation comes from collapsing two separate problems into one word — “embolism.” Filler can harm a blood vessel in two basic ways: by pressing on it from outside (a mass of filler compressing a vessel, starving the tissue it feeds), or by getting inside it and being carried off as a plug. It's the second mechanism — an intravascular embolus — that the headlines are worried about.

And here the crucial fork is which type of vessel the filler enters.

Arterial route

The real facial danger — but it doesn't go to the lungs. Arteries carry blood away from the heart under high pressure. If filler is forced into a facial artery hard enough to push backwards against that pressure, it can travel retrograde — upstream — into the vessels feeding the eye and brain.

This is the mechanism behind the genuinely feared facial complications: skin death (necrosis) and, rarely, blindness or stroke, when filler reaches the ophthalmic artery and its branches. The high-risk zones are the glabella, nose, forehead, under-eye and nasolabial folds. It is catastrophic — but it is an arterial, head-and-neck event. It does not produce a pulmonary embolism.

Venous route

This is the only route to the lungs. Veins carry blood back to the heart, at low pressure. Anything that enters a vein follows that current: to the right side of the heart, then straight into the pulmonary arteries of the lungs. Lodge enough material there and you have a pulmonary embolism.

On the face, the principal venous danger zone is the temple, which contains large, high-flow veins (the middle temporal and sentinel veins). There is also a second, chemical mechanism: foreign material can trigger an inflammatory lung injury — bleeding into the air sacs — rather than a simple mechanical plug.

But facial veins are small, and facial volumes are tiny. That combination is the heart of this whole story.

Why volume and location decide everything

A pulmonary embolism is a numbers game. To meaningfully obstruct the lungs' blood supply, you generally need a large bolus of material reaching a large vein. Now compare two procedures:

• Facial filler:  typically a fraction of a millilitre to a couple of millilitres per area, deposited slowly, in tiny aliquots, through fine needles or cannulas, into a region drained by small veins. Even an accidental venous entry rarely delivers enough material to threaten the lungs.

• Body filler — buttocks, breasts, genitals:  tens, sometimes hundreds, of millilitres. Large-bore cannulas. High injection pressure. Large, deep, high-flow draining veins sitting right there. This is the configuration that produces a clinically significant embolic load.

That is the physical reason the death toll clusters where it does. When a critical pulmonary embolism does occur, the cascade is brutally quick: the blocked lung vessels cause pressure to back up against the right side of the heart, the right ventricle strains and fails, the left side can no longer fill, blood pressure collapses, oxygen levels plummet — and the person becomes lightheaded, then collapses. It explains the shape of the Ascher story. It does not tell us where the filler was.

The evidence ledger

Every documented filler-related lung embolism I could trace

This is the part nobody on social media has done. I went through the published case reports and reviews — including a 2025 review that found only eight prior reports of any hyaluronic-acid-related lung complication ever published worldwide. Here is the pattern, laid out plainly.

Facial sites — the only true comparison to lip and cheek work

• One case, 2014. Hyaluronic acid to the face, performed at a hair salon by an unlicensed person. A non-thrombotic pulmonary embolism followed. The patient was ventilated in intensive care and survived, fully recovered within a month.

Body sites — where the fatalities cluster

• Buttock augmentation, silicone (a permanent, non-HA material): the source of multiple fatal embolic events, and the pattern behind most “filler death” headlines.

• Vaginal hyaluronic acid injection: fatal pulmonary embolism reported.

• Penile hyaluronic acid injection: fatal pulmonary embolism reported.

• Breast filler: fatal and near-fatal embolic events documented.

The pattern is the point: the single facial case survived; every fatality involved large-volume injection into a body site, frequently with a permanent, non-HA material and/or an unqualified injector.

The 2014 facial case, in detail — because it's the one everyone half-remembers

This is the case cited as proof that “facial filler causes lung embolism.” It deserves to be read properly. A 35-year-old woman received hyaluronic acid filler to her face — at a hair salon, from someone with no medical licence. Three days later she developed breathlessness, was admitted to intensive care, needed a ventilator, and showed the skin and breathing signs of a non-thrombotic embolism. She was treated, weaned off the ventilator, discharged on day eight, and had completely recovered a month later, with her lungs back to normal on the follow-up scan.

So yes — facial filler can, very rarely, reach the lungs. But the only documented instance happened in a salon chair, not a clinic, and the patient lived. That is a meaningfully different headline from the one we've been given.

The procedures that actually kill people

Why the buttock, not the cheek, is where regulators are looking

If you take one thing from the ledger, take this: the lethal events sit at the body sites. Large-volume gluteal, genital and breast filler — especially with permanent materials like silicone, and especially in the hands of non-medics — is a categorically different risk from facial aesthetics. This isn't a clinic trying to make its own services sound safe; it's exactly where the law is moving.

In September 2024, Alice Webb became the first person in the UK known to have died following a non-surgical cosmetic procedure — a “liquid” Brazilian butt lift carried out by a non-medical practitioner. Her death has driven the entire direction of UK regulation. Under the licensing framework the government set out in 2025, procedures are being sorted by clinical risk:

• Red (highest risk): liquid BBLs and buttock, breast and genital filler — to be restricted to regulated healthcare professionals working in inspected premises. This is the tier being legislated first.

• Amber (medium risk): botulinum toxin and facial dermal fillers — to require licensing and the oversight of a named, regulated healthcare professional.

• Green (lower risk): treatments such as microneedling and superficial peels.

The hierarchy isn't arbitrary. It's the same hierarchy the case reports describe.

What this means if you're considering facial treatment

The honest takeaway is not “filler is dangerous.” It's that risk in this field is decided almost entirely by four things: what is being injected, where, with what product, and by whom. Get those right and facial aesthetics sits among the safest things you can have done to your face. Get them wrong — a large volume, a high-risk site, a permanent material, an unqualified injector — and the risk climbs steeply. (This is particularly important when considering a non-surgical rhinoplasty).

So the practical questions worth asking before any injectable:

• Who is actually holding the syringe, and what is their medical registration? In the UK, look for a doctor, nurse or dentist on a statutory register — GMC, NMC or GDC. More so, ask for their experience - how long have they been doing x treatment? How many people have they treated with y? How many serious complications have they had, if any?

• What product are they using? A reversible hyaluronic acid is a fundamentally different risk profile from a permanent material.

• Do they understand the vascular anatomy — and what they'd do if something went wrong? A practitioner who can talk you through their complication protocol, including hyaluronidase to dissolve HA filler, is telling you something important about their training.

• Where is it being done? Inspected, clinical premises — not a salon back-room or a kitchen table.

None of this is brand loyalty. It is the single most evidence-based thing you can do to make an injectable safe.

The warning signs worth knowing

If you've had any injectable and something feels wrong, don't wait politely to see if it settles.

• On the same day, locally: sudden vision changes, severe or escalating pain out of proportion to the procedure, or skin that turns white, blue, dusky or mottled. Arterial occlusion has a short treatment window — contact your injector immediately.

• In the hours or days after, systemically: sudden breathlessness, chest pain, coughing up blood, a racing heart, or fainting. These warrant emergency assessment — call 999. They are far more associated with large-volume body procedures, but any new breathlessness after an injectable should be taken seriously.

• 
  

So — can facial filler cause a pulmonary embolism?

Honestly? In theory, very rarely, yes — by the venous route, most plausibly from the temple, and even then almost vanishingly so. In the published record of global medicine it has been reported to reach the lungs once, in an illegal salon, and that patient survived. No one in the literature has died of a pulmonary embolism caused specifically by facial filler.

The deaths — including, very probably, the one now attached to the Estée Lauder name — belong to a different procedure entirely: large-volume body filler, frequently performed by people who should never have been holding the syringe. That distinction has been lost in the retelling, and losing it does patients a disservice. It frightens people away from well-performed facial treatment while obscuring the procedures that are actually dangerous.

The lesson of Kendal Ascher's death isn't that injectables are roulette. It's the oldest lesson in this field, stated more sharply than ever: what you have done, where, with what, and by whom — those are not details. They are the entire risk.

Frequently asked questions

Can lip or cheek filler travel to my lungs?

It is extraordinarily unlikely. Facial veins are small and facial filler volumes are tiny, so even an accidental injection into a vein rarely carries enough material to reach and obstruct the lungs. In all of published medicine there is a single reported instance of facial filler causing a lung embolism — performed by an unlicensed person in a hair salon — and the patient recovered fully.

Has anyone actually died from facial dermal filler?

Not from a pulmonary embolism caused by facial filler — there is no such published case. The recognised severe facial complications are different: skin necrosis and, rarely, blindness or stroke caused by filler entering an artery and travelling toward the eye or brain. These are the risks a properly trained injector is trained to prevent and to manage.

Then what killed the Estée Lauder executive?

A pulmonary embolism of filler material — that much the Medical Examiner confirmed. What was never stated is where on his body the filler was placed. Given that fatal filler embolism is overwhelmingly a large-volume, body-site event, that is the most likely explanation, but it has not been confirmed publicly. It is honest to say the site is unknown.

Is Botox the same risk?

No. Botulinum toxin is not a filler — it's a tiny volume of a muscle-relaxing protein, not a gel that can form an embolic plug. It carries its own (different and generally minor) considerations, but the embolism mechanism discussed here does not apply to it.

How do I make sure my treatment is safe?

Choose a registered medical professional (GMC, NMC or GDC), working from clinical premises, using reversible hyaluronic acid products, who can explain their complication protocol before they treat you. The evidence is clear that who performs the procedure — and where, and with what — is the dominant factor in your safety.

If you're considering treatment and want it done properly, you can book a consultation here.

You can view all of our treatments here.

ABOUT THE AUTHOR

Rachel Roberts is an NMC-registered Independent Nurse Prescriber with over 20 years of clinical experience and the Clinical Director of Sebastian Rose Medical Aesthetics, a medically-led clinic in Cardiff. She performs all prescribing and injectable treatment personally. This article reflects the published medical evidence and reporting available as of June 2026.

References

1. Jang JG, et al. Non-thrombotic pulmonary embolism following facial hyaluronic acid filler injection — case report. 2014 (PMID 25237381).

2. Review of acute pulmonary complications following cosmetic hyaluronic acid dermal filler, identifying only eight prior reported HA-related pulmonary cases worldwide. Respirology Case Reports (Wiley), 2025.

3. Zhao F, et al. Vascular complications of facial soft-tissue filler: mechanisms and prevention. Diagnostics (MDPI), 2024 — source of the ~5.5 million annual filler-procedure figure.

4. Forensic case report of fatal filler-related embolism. Sud Med Ekspert. 2025;68(1):59–62.

5. New York City Office of Chief Medical Examiner findings, as reported by the New York Post, WWD and Cosmetics Business, June 2026 (Kendal Ascher).

6. Death of Alice Webb following a non-surgical (“liquid”) Brazilian butt lift, September 2024 — UK news reporting; ongoing investigation.

7. Department of Health & Social Care. Licensing of non-surgical cosmetic procedures in England, consultation and response, 2025; House of Commons Library briefing CBP-10331.

This article is general educational information about cosmetic procedures and is not personal medical advice. It does not replace an individual assessment by a qualified clinician. If you are worried about symptoms after any procedure, seek medical attention promptly; in an emergency, call 999.

Sebastian Rose · Medically-led aesthetics · 39 Charles Street, Cardiff · sebastianrose.co.uk